Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab emtansine)
Catalog No.
F1401
Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab emtansine)
Featured Products
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-conjugated molecule (ADC) that combines the antitumor properties of the HER2-targeting trastuzumab with the cytotoxic activity of the microtubule inhibitor DM1. Trastuzumab emtansine is being investigated in advanced breast cancer.
145 kDa
Dry ice
1018448-65-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Kadcyla, PRO132365, trastuzumab-MCC-DM1
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P04626
Human
DM1
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
ERBB2 / HER2 / CD340
Please avoid freeze-thaw cycles.